MediWound Ltd (MDWD)
16.95
-0.34
(-1.97%)
USD |
NASDAQ |
May 17, 16:00
16.95
0.00 (0.00%)
After-Hours: 20:00
MediWound Enterprise Value: 119.63M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 119.63M |
May 16, 2024 | 122.57M |
May 15, 2024 | 127.79M |
May 14, 2024 | 127.41M |
May 13, 2024 | 125.99M |
May 10, 2024 | 122.86M |
May 09, 2024 | 126.56M |
May 08, 2024 | 126.94M |
May 07, 2024 | 138.33M |
May 06, 2024 | 137.85M |
May 03, 2024 | 135.48M |
May 02, 2024 | 137.28M |
May 01, 2024 | 141.36M |
April 30, 2024 | 135.10M |
April 29, 2024 | 140.89M |
April 26, 2024 | 131.59M |
April 25, 2024 | 126.08M |
April 24, 2024 | 125.42M |
April 23, 2024 | 114.22M |
April 22, 2024 | 108.05M |
April 19, 2024 | 108.14M |
April 18, 2024 | 119.72M |
April 17, 2024 | 123.99M |
April 16, 2024 | 131.97M |
April 15, 2024 | 110.33M |
Date | Value |
---|---|
April 12, 2024 | 110.23M |
April 11, 2024 | 108.90M |
April 10, 2024 | 103.49M |
April 09, 2024 | 109.47M |
April 08, 2024 | 100.83M |
April 05, 2024 | 101.88M |
April 04, 2024 | 103.78M |
April 03, 2024 | 100.45M |
April 02, 2024 | 91.34M |
April 01, 2024 | 92.96M |
March 28, 2024 | 93.72M |
March 27, 2024 | 101.78M |
March 26, 2024 | 106.15M |
March 25, 2024 | 108.71M |
March 22, 2024 | 110.04M |
March 21, 2024 | 109.85M |
March 20, 2024 | 106.72M |
March 19, 2024 | 107.76M |
March 18, 2024 | 107.76M |
March 15, 2024 | 110.33M |
March 14, 2024 | 97.71M |
March 13, 2024 | 98.72M |
March 12, 2024 | 105.27M |
March 11, 2024 | 108.50M |
March 08, 2024 | 116.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
12.55M
Minimum
Apr 03 2020
143.38M
Maximum
Feb 05 2021
63.15M
Average
54.14M
Median
Jul 18 2019
Enterprise Value Benchmarks
Compugen Ltd | 138.22M |
Pluri Inc | 33.13M |
BioLine Rx Ltd | 17.94M |
Can Fite Biofarma Ltd | 2.955M |
BiomX Inc | 14.99M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.743M |
Revenue (Quarterly) | 5.338M |
Total Expenses (Quarterly) | 9.443M |
EPS Diluted (Quarterly) | -0.19 |
Gross Profit Margin (Quarterly) | 13.47% |
Profit Margin (Quarterly) | -32.65% |
Earnings Yield | -4.53% |
Normalized Earnings Yield | -4.535 |